The short answer
After surgery for kidney cancer, your follow-up schedule is built from your pathology report — stage, grade and features sort you into a risk group that sets how often you are imaged. Kidney cancer can return late: about 30% of recurrences are diagnosed more than five years after surgery.
There is no single kidney cancer follow-up schedule — imaging frequency comes from a risk group based on your surgical pathology.
Low-risk means abdominal imaging at roughly 12 and 24 months then 48 and 60; high-risk means every six months through year three, then annually to five years and beyond.
CT or MRI with and without contrast is preferred for the abdomen; chest X-ray is used for lower-risk groups and chest CT is preferred for higher-risk ones.
About 30% of recurrences after surgery are diagnosed beyond five years, which is why surveillance does not simply stop at the five-year mark.
Choose how you want to understand this
The full explanation.
What follow-up is actually for
Surgery for kidney cancer — removing part of the kidney (partial nephrectomy) or all of it (radical nephrectomy) — is often curative. Follow-up exists for three separate reasons, and it helps to keep them apart:
- To find a recurrence early enough to treat, whether in the kidney bed or elsewhere.
- To watch your remaining kidney function, which matters more after surgery than before.
- To make sure someone is still actively looking after year five.
The schedule is built from your pathology report
There is no single kidney cancer follow-up schedule. The American Urological Association sorts people into risk groups using the surgical pathology:
- Low risk — pT1, grade 1 to 2
- Intermediate risk — pT1 grade 3 to 4, or pT2 any grade
- High risk — pT3, any grade
- Very high risk — pT4, positive nodes, sarcomatoid or rhabdoid features, or positive margins
The imaging follows from there, roughly:
- Low risk — abdominal imaging at about 12 and 24 months, then around 48 and 60 months.
- Intermediate risk — at about 6, 12, 24 and 36 months, then 48 and 60 months.
- High risk — every 6 months through the first 3 years, then annually to 5 years, continuing out to 7 to 10 years.
- Very high risk — the most frequent schedule, starting at around 3 months.
CT or MRI with and without contrast is preferred for the abdomen; ultrasound may alternate with cross-sectional imaging in lower-risk groups after the first two years. Chest imaging runs in parallel — chest X-ray for lower-risk groups, chest CT preferred for higher-risk. Every visit should also include bloodwork: creatinine, eGFR and urinalysis.
Ask for your risk group and your schedule in writing. Both come straight off your pathology report, and having them on paper makes the years ahead far less confusing — especially if your care moves between urology, oncology and primary care.
Late recurrence is a real feature of this cancer
Kidney cancer can come back many years after treatment. About 30% of recurrences after surgery are diagnosed beyond five years. That is unusual among solid tumours, and it is why kidney cancer follow-up does not simply stop at the five-year mark. Past that point, imaging becomes a shared decision weighing your risk group, your kidney function, cumulative contrast and radiation exposure, and your own preference.
This fact cuts both ways. It is a reason not to assume you are finished at five years. It is not a reason to expect a recurrence — most people in the lower risk groups never have one.
If you were offered treatment after surgery
For some people with higher-risk stage II or stage III disease, immunotherapy after surgery is part of the plan. If that applies to you, follow-up includes monitoring for immune-related side effects — thyroid, liver, bowel, skin — on top of cancer surveillance. Those are two different sets of checks running on two different schedules, and it is worth being clear about which appointment is for which.
Kidney function is part of the picture
After a partial or full nephrectomy, protecting what remains matters. Blood pressure control, staying hydrated, care with anti-inflammatory painkillers, and reviewing any medication that is hard on the kidneys all become part of routine follow-up. If your eGFR is declining or protein appears in your urine, a nephrology referral is appropriate — that is a normal part of good follow-up, not a sign something has gone wrong.
Scan anxiety is normal and manageable
Most people describe the weeks before a scan as harder than the scan itself. A few things that help: book the scan and the results appointment close together and get both dates up front; ask who calls with results and by when; and decide in advance whether you want to see results in the patient portal before speaking to your clinician, since portal releases are often immediate and worded for clinicians.
Between scans, symptoms usually worth reporting promptly are blood in the urine, a persistent new cough or breathlessness, new bone pain, unexplained weight loss, or new pain in the surgical area.
Sources
Words to know
Tap any term to see what it means.
Common questions
Why does my follow-up look different from someone else's?
Because it is built from your pathology. The AUA sorts people into low, intermediate, high and very high risk based on tumour stage, grade and features like sarcomatoid change or positive margins. Each group gets a different imaging frequency, so two people who both had a kidney removed can have quite different schedules.
Does surveillance stop after five years?
Not automatically. Kidney cancer is notable for late recurrence — about 30% of recurrences after surgery are found beyond five years. Past that point, imaging becomes a shared decision that weighs your risk group, kidney function, contrast and radiation exposure, and your own preferences.
Do I need contrast every time?
CT or MRI with and without intravenous contrast is preferred for abdominal imaging, but kidney function affects what is safe. In lower-risk groups ultrasound may alternate with cross-sectional imaging after the first couple of years. Ask what your creatinine and eGFR mean for your imaging plan.
What symptoms should I report between scans?
Blood in the urine, a persistent new cough or shortness of breath, new bone pain, unexplained weight loss, or new pain around the surgical area are worth reporting promptly rather than waiting for the next appointment. Most turn out to be something else, but reporting them is how the schedule is meant to work.
Who is supposed to be ordering my scans?
This is worth pinning down explicitly, because kidney cancer follow-up often shifts between urology, medical oncology and primary care over the years. Ask who owns the schedule, who orders the imaging, who calls with results, and what happens if you move or change insurance.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the federal sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Written by: Cancer Explained Editorial TeamSources last checked: 2026-07-30Last updated: 2026-07-30Next planned review: 2027-07-30
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source verified. This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Cancer Explained is not clinician-reviewed, and that is a deliberate design choice rather than a gap we are waiting to close. We restate published federal guidance and cite it; the authority belongs to the source, not to us. That is why every page names where its claims come from — so you can verify us instead of trusting us. Use it to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source verified — This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.
Human medical review: not completed. Cancer Explained is not clinician-reviewed, and that is a deliberate design choice rather than a gap we are waiting to close. We restate published federal guidance and cite it; the authority belongs to the source, not to us. That is why every page names where its claims come from — so you can verify us instead of trusting us. Use it to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share